Drug Shortage Report for MOBICOX
Report ID | 4323 |
Drug Identification Number | 02242785 |
Brand name | MOBICOX |
Common or Proper name | Mobicox |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MELOXICAM |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AC |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-04-03 |
Actual start date | |
Estimated end date | 2017-05-19 |
Actual end date | 2017-05-09 |
Shortage status | Resolved |
Updated date | 2017-05-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2017-05-10 | English | Compare |
v9 | 2017-05-09 | French | Compare |
v8 | 2017-05-09 | English | Compare |
v7 | 2017-05-05 | French | Compare |
v6 | 2017-05-05 | English | Compare |
v5 | 2017-05-01 | French | Compare |
v4 | 2017-05-01 | English | Compare |
v3 | 2017-04-04 | English | Compare |
v2 | 2017-03-25 | French | Compare |
v1 | 2017-03-25 | English | Compare |
Showing 1 to 10 of 10